Mithrl builds a scientific decision engine for biopharma and research teams. Its biomedical world model combines validated biological knowledge with each organization’s data, then uses AI agents and workflows to help scientists analyze experiments, assess hypotheses and accelerate drug-discovery decisions; the company is preparing its next-generation platform for broader deployment.
OV
Obvious Ventures
Activity from announced rounds
Activity in this selectioncincytech-c4d9e576
- Rounds participated in
- 8
- Confirmed lead rounds
- 1 6 roles undisclosed
- New companies
- 8 First participation on record · 0 follow-on
- Funding in participating rounds
- $271.9M 8 disclosed · full round size, not this investor’s share
By stage
By primary sector
2 more
Mobility1
Proptech1
By country
Rounds
8 in this selectionMithrl
$20MSeries A
LeadGenHealth.ai
AI agents automate administrative and revenue-cycle workflows for healthcare providers, DME suppliers and health plans.
$16.5MSeries A
ParticipantGritt
Combines robotics and AI to automate labor-intensive infrastructure and construction site tasks
$32.4MSeed+Series A
Role not disclosedHostie
AI-powered virtual concierge for restaurants
$12MSeries A
Role not disclosedRadical Numerics
Builds multimodal AI models that read, write, and design across DNA, RNA, and proteins
$50MSeed
Role not disclosedIterative Health
Powers the acceleration of clinical research to transform patient outcomes
$77MSeries C
Role not disclosedHalcyon
Provides AI platform for analyzing and accessing complex energy data for industry professionals
$21MSeries A
Role not disclosedFleetzero
Builds electric and hybrid marine propulsion systems for commercial vessels
$43MSeries A
Role not disclosed